Market Overview

UPDATE: Credit Suisse Initiates Coverage On Progressive On ASI Deal


In a report published Wednesday, Credit Suisse analyst Ryan Tunis initiated coverage on Progressive Corp (NYSE: PGR) with a Neutral rating and $29.00 price target.

In the report, Credit Suisse noted, "The ASI relationship demonstrates PGR's commitment to increasing policyholder life expectancy across the firm, which we view as the most important driver of policy growth, particularly in agency, in which we see PGR facing increasing pressure from other large players such as TRV. The drawback, in our view, is the future capital outlay likely required to grow the business, which we think will limit PGR's ability to pay a special dividend.

"Although homeowners has been viewed as a lower-multiple business than auto, we think that the fact that (1) ASI's book is heavily reinsured, and (2) auto growth benefits long-term from bundling, should offset multiple compression from shift to home."

Progressive closed on Tuesday at $27.20.

Latest Ratings for PGR

Mar 2019Credit SuisseMaintainsOutperformOutperform
Feb 2019CitigroupMaintainsNeutralNeutral
Jan 2019BarclaysUpgradesUnderweightOverweight

View More Analyst Ratings for PGR
View the Latest Analyst Ratings

Posted-In: Credit Suisse Ryan TunisAnalyst Color Initiation Analyst Ratings


Related Articles (PGR)

View Comments and Join the Discussion!

Latest Ratings

DRIBank of AmericaReiterates130.0
PVACNorthland SecuritiesUpgrades0.0
NKEWells FargoMaintains80.0
DRIWells FargoMaintains120.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Trader Essentials
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Idera Announces FDA Orphan Drug Designation for IMO-8400 for the Treatment of Diffuse Large B-Cell Lymphoma

EUR/USD Moves Higher